These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3984279)

  • 1. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and experimental research on the drug-metabolizing function of the liver in peritonitis].
    Khakimov ZZ; Nadzhimutdinov KN; Akhmedov RM
    Farmakol Toksikol; 1988; 51(2):80-2. PubMed ID: 3378613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of benzonal on the drug-metabolizing function of the liver in pathological states].
    Nadzhimutdinov KN; Khakimov ZZ
    Farmakol Toksikol; 1988; 51(3):72-5. PubMed ID: 3410034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of diabetes mellitus on drug metabolism in man.
    Daintith H; Stevenson IH; O'Malley K
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK; Nanivadekar SA; Billimoria FR
    Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of cimetidine on antipyrine metabolism.
    Piekoszewski W; Rutkowska A; Brandys J
    Pol J Pharmacol; 1993; 45(4):421-9. PubMed ID: 8118484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
    Abramson FP; Lutz MP
    Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B; Mehta S; Nain CK; Mathur VS
    Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings].
    Van Boxtel CJ; Breimer DD; Danhof M
    Br J Pharmacol; 1980 Jan; 68(1):121P. PubMed ID: 7357141
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of age, sex and breed on antipyrine disposition in calves.
    Depelchin BO; Bloden S; Michaux C; Ansay M
    Res Vet Sci; 1988 Mar; 44(2):135-9. PubMed ID: 3387662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.